Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I Study of Oral Edaravone in Healthy Adult Males
NCT04481750Phase 1Completed
- Sponsor
- Shionogi & Co., Ltd.
- Start
- Mar 2018
- Primary completion
- Aug 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of edaravone (10 cohorts), sponsored by Shionogi & Co., Ltd. Primary endpoints: Number of Participants With Adverse Events and Adverse Drug Reactions, Area Under the Concentration Versus Time Curve of Unchanged Edaravone and 18 more. Started Mar 2018; status: completed.
02
Drugs
edaravone
Beyond the preview
Go deeper on NCT04481750.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04481750.